Diversity in Clinical Trials: A Regulatory Imperative
A recent study has shown that Americans of color participating in clinical trials received significantly less inclusion than white Americans. This analysis, conducted by Komodo Health, shows that 85% of participants in oncology trials were white over the past five years. For reference, black participants made up only 7% of the trial population. This should be further scrutinized as black patients currently have the highest mortality and lowest survival rate of any other ethnic/racial group in nearly all types of cancer cases. Komodo has reaffirmed that...